RxDoctor Payments Data

Matthew West, MD

Physical Medicine & Rehabilitation · Omaha, NENPI 1962596791

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Si-bone, Inc. at 50.9% of the total. Reporting peaked in 2019 at $160 and has fallen 89.6% since, to $17 in 2025.

$347in general payments, 2019–2025

Across 13 payments — averaging $26.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$177
  • AbbVie$42
  • Johnson & Johnson$34
  • Conetic Solutions, Inc.$29
  • Amgen$21
  • Boston Scientific$17
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$347100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$347 in reported general payments places this provider in the 60th percentile of 57 physical medicine & rehabilitation providers in Nebraska.

See all physical medicine & rehabilitation providers in Nebraska

Medicare billing

Part B allowed, 2024
$270,465
Medicare patients
594
Services billed
19,668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin523$5,428
Pregabalin200$3,537
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen149$2,206
Duloxetine Hcl133$1,194
Celecoxib66$890
Tramadol Hcl192$827
Calcitonin-SalmonCalcitonin,salmon,synthetic13$772
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen50$754
Meloxicam210$544
Methylprednisolone70$486
Tizanidine Hcl32$453
Methocarbamol55$382
Cyclobenzaprine Hcl75$372
Diclofenac Sodium19$274
Baclofen23$191

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →